Bz-L-Thr-OMe

Bz-L-Thr-OMe is an L-threonine methyl ester bearing a benzyl (Bz) N-protecting group, giving a chiral amino acid ester with a stereogenic center at the threonine alpha-carbon and a side-chain hydroxyl group suitable for selective functionalization. The structure contains an N-benzoyl amide, a methyl ester at the C-terminus, and a free secondary alcohol that can be protected, oxidized, or converted into leaving groups under controlled conditions. The benzoyl protection pattern supports stable handling during peptide coupling while maintaining compatibility with common peptide synthesis workflows that require orthogonal deprotection. The resulting reactivity profile makes Bz-L-Thr-OMe a practical chiral amino acid intermediate for protected amino acid synthesis, peptide building block preparation, and downstream derivatization where side-chain chemistry is preserved or selectively masked.

1. Protected Amino Acid Synthesis

Bz-L-Thr-OMe is used in protected amino acid synthesis and chiral building block preparation for generating threonine-derived intermediates with defined N- and C-terminal functionality. The N-benzoyl amide and methyl ester combination provides a controlled coupling handle while the L-configuration at the alpha-carbon maintains stereochemical integrity throughout intermediate transformations. The side-chain hydroxyl can be selectively protected to enable orthogonal chemistry, allowing subsequent peptide coupling without undesired side reactions. Downstream, Bz-L-Thr-OMe can be converted into activated threonine fragments or further ester/acid forms used in fine chemical synthesis and research-grade peptide construction.

2. Peptide Coupling Chemistry

Bz-L-Thr-OMe serves as a peptide synthesis-compatible threonine building block for assembling protected peptide sequences where N-benzoylation and ester masking influence coupling strategy. The protected amide nitrogen and esterified carboxyl group enable controlled conversion into coupling-ready derivatives, supporting stepwise peptide bond formation while minimizing racemization risk at the stereogenic center. The pendant hydroxyl on the threonine side chain can be managed through temporary protection or selective activation, supporting synthesis of peptides that require intact threonine functionality or later post-coupling modification. The resulting peptide intermediates can be used for library generation, mechanistic studies, and scaffold elaboration in amino acid and peptide chemistry.

3. Side-Chain Functionalization

Bz-L-Thr-OMe is applied in side-chain functionalization workflows that exploit the threonine secondary alcohol for targeted derivatization. The free hydroxyl group can undergo protection for orthogonal peptide chemistry, oxidation to generate carbonyl-containing analogs, or conversion to ether or carbonate derivatives that tune polarity and reactivity. The presence of the N-benzoyl group and methyl ester helps maintain chemoselectivity by reducing competing reactions during side-chain transformations. The functionalized threonine derivatives derived from Bz-L-Thr-OMe can feed peptidomimetic construction, structure-activity relationship studies, and synthetic intermediate preparation for larger biomolecule analogs.

4. Bioconjugation Linker Design

Bz-L-Thr-OMe supports chemical biology and bioconjugation linker design by providing a stereodefined threonine motif with an alcohol handle for conjugation chemistry. The side-chain hydroxyl enables attachment strategies such as ether formation or carbonate/ester-based linkers that can be engineered for stability or controlled hydrolysis depending on downstream design. The benzoyl-protected amide and ester functionality can be transformed into conjugation-ready carboxylate or activated ester forms while preserving the L-stereochemistry relevant to recognition in peptide-like constructs. Conjugation products derived from this amino acid intermediate can be used to generate labeled peptides, affinity probes, or biomolecule-modified reagents for biochemical research and analytical development.

5. Pharmaceutical Intermediate Preparation

Bz-L-Thr-OMe is utilized in pharmaceutical intermediate preparation where protected amino acid esters act as controlled precursors for threonine-containing fragments. The combination of N-benzoyl protection and methyl ester masking supports manufacturing-oriented route design by enabling predictable handling, selective functional group transformations, and staged deprotection strategies. The chiral threonine core provides a stereochemically defined element for incorporation into peptide-like intermediates, peptidomimetics, or constrained scaffolds used in process chemistry. Downstream conversion to acid forms, activated derivatives, or side-chain-modified analogs can support fine chemical synthesis and specialty chemical production requiring consistent stereochemical outcomes.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries